pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Oncology · news · pharmadog
← back to Oncology
News · Oncology
1,499
stories
Jul 27, 26
FDA has recommitted to adcomms—but to what end?
biospace
Jul 27, 26
Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseases
fiercebiotech
Jul 27, 26
FDA finalizes three guidances to broaden cancer clinical trial eligibility
raps
Jul 24, 26
Sanofi halts development of troubled immune drug in eczema
biopharma dive
Jul 24, 26
Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech
biospace
Jul 24, 26
Novo escalates legal fight with Lilly; J&J reinforces ‘dominance’ in multiple myeloma
biopharma dive
Jul 24, 26
Study of Yescarta patients reveals genetic red flags for CAR-T therapy side effects
fiercebiotech
Jul 24, 26
Summit has less than a year of cash runway left as PD-1/VEGF verdict nears
biospace
Jul 24, 26
Sunny Pharmtech, Inc. Issues Voluntary Nationwide Recall of Cyclophosphamide for Injection, USP to the User Level Due to the Presence of Particulate Matter
fda medwatch
Jul 24, 26
FDA panel endorses broader use of certain peptides
biopharma dive
Jul 23, 26
Chutes & Ladders—Biogen R&D vet gets in Formation
fiercebiotech
Jul 23, 26
FDA panel confronting peptide controversy
stat
Jul 23, 26
Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drug
endpoints
Jul 23, 26
From Abu Dhabi to Brazil, every region is vying for the ‘new emerging economy’ of biotech
fiercebiotech
Jul 23, 26
BeOne commits $300M to US manufacturing expansion, creating 120 new jobs
biospace
Jul 23, 26
Roche's late stage pipeline 'so full,' CEO Schinecker not feeling pressure to add on
biospace
Jul 23, 26
GSK’s $10.6B Nuvalent bet pays off early as FDA approves lung cancer drug
biospace
Jul 23, 26
Scancell to go public after winning reverse merger bid for troubled Neuphoria
fiercebiotech
Jul 23, 26
Make or break: Commercial hires critical for success
biospace
Jul 23, 26
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
fiercebiotech
Jul 22, 26
Webinar: From Clinical to Commercial: Talent Strategies for Biopharma Growth
biospace
Jul 22, 26
GSK lung cancer drug gets speedy approval following $10.6B deal
biopharma dive
Jul 22, 26
Former FDA cancer chief Pazdur says the agency should restructure
endpoints
Jul 22, 26
FDA approves Nuvalent's cancer drug, a week after GSK closed $10.6B buyout
endpoints
Jul 22, 26
Summit and Akeso sharpen case for ivonescimab with new Western data
biospace
Jul 22, 26
NIH joins Trump’s $5B AI mission with biomedical research push
fiercebiotech
Jul 22, 26
STAT+: Pharma tries to tamp down broad China restrictions
stat
Jul 22, 26
Summit counters PD-1/VEGF skeptics; Celldex drug fails skin disease study
biopharma dive
Jul 22, 26
6 companies hiring in Cambridge now
biospace
Jul 22, 26
Summit reports two-year survival data for Western patients, though context lacking
endpoints
← prev
page 29 of 50
next →
